Presentation Information
[Pj-006-4]Clinical characteristics and issues of patient selection eligible for lecanemab at our hospital
Fukuko Nishida1, Makoto Hideshima1, Yasutaka Murakami1, Junki Jinno1, Takeshi Ikegami1, Toshiki Yamano1, Toshihisa Tanaka3, Kazuo Hashikawa3, Hideaki Kanki1,2, Hiroyuki Hashimoto1 (1.Department of Neurology, Osaka International Medical & Science Center, Japan, 2.Department of Neurology, Osaka University, Japan, 3.Center for Dementia-Related Disease, Osaka International Medical & Science Center, Japan)